Return to The CPNP Perspective issue main page.< Previous Article  Next Article >

CPNP 2019 will once again promote research in the field with two poster sessions at the 22nd Annual Meeting in Salt Lake City, Utah, April 7-10, 2019. Take advantage of this opportunity to submit an abstract of your research in one of five categories by January 7, 2019. Posters will be displayed on Monday, April 8, Tuesday, April 9, and published on cpnp.org and in the May 2019 issue of the Mental Health Clinician. Abstract categories include:

  • Original Research: Abstracts should describe original research in therapeutics, pharmacodynamics, pharmacoeconomics, outcomes, drug utilization, kinetics, genetics and academic pursuits. Abstracts must not have been published in abstract form nor presented as a poster elsewhere before the CPNP 2019 Meeting.
  • Encore Presentation: Abstracts of papers that have been previously presented and peer reviewed. Submission must include where it was previously presented or the abstract will be disqualified. Encore submissions are not eligible for any of the award categories and should not be submitted for award consideration.
  • Work in Progress (WIP): Abstracts describing preliminary results or status of ongoing work may be submitted by principal investigators at any stage of their career. Abstracts submitted without results at the time of submission will be considered for this category only.
  • Innovative Practices: Abstracts describing the development, justification, documentation, and/or delivery of innovative services or activities applicable to psychiatric and neurologic pharmacy. The descriptive abstract should not duplicate any other poster category and should describe the development of innovative services/activities and should provide background/rationale, a description of the innovative service, the impact on patient care/institution and a conclusion.
  • Therapeutic Case Report: Abstracts describing the various aspects of pharmaceutical care relating to individual psychiatric and/or neurological pharmacy cases. Abstracts should provide a complete patient history including age, gender, time from first diagnosis, social background, and details of, and response to, previous and current treatment(s). Cases should include background, complete patient history, review of literature, and conclusion.

When submitting an abstract, researchers can select one of the five award categories to be considered for:

  • Research Trainee
  • Original Research
  • Innovative Practices
  • Therapeutic Case Report
  • CPNP Foundation Strategic Goals

The abstract submission center is open now and submissions are due January 7, 2019. More information on abstracts and awards is available online at cpnp.org/2019.

Two Scientific Poster Sessions will be held at CPNP 2019. Plan to attend both poster sessions to view the exciting research being done across the country with varying levels of practice experience in a variety of practice settings. At the same time converse with the researchers to gain insights into their work and network with colleagues also perusing the scientific posters. Sessions will be held late afternoon/evenings of Mondfya, April 8 and Tuesday, April 9.

 

Return to The CPNP Perspective issue main page.< Previous Article  Next Article >